Trials / Conditions / Malignant Ovarian Brenner Tumor

Malignant Ovarian Brenner Tumor

7 registered clinical trials studyying Malignant Ovarian Brenner Tumor.

Status	Trial	Sponsor	Phase
Terminated	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors NCT03641287	University of Washington	N/A
Terminated	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, F NCT02923739	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Can NCT02068794	Mayo Clinic	Phase 1 / Phase 2
Unknown	Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previo NCT00719303	Gynecologic Oncology Group	Phase 3
Completed	First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ov NCT01097746	M.D. Anderson Cancer Center	Phase 2
Completed	Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epi NCT00951496	National Cancer Institute (NCI)	Phase 3
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—